Catalent
CTLT
#1496
Rank
โ‚น982.62 B
Marketcap
โ‚น5,414
Share price
0.00%
Change (1 day)
48.34%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Revenue for Catalent (CTLT)

Revenue in 2024 (TTM): โ‚น368.89 Billion

According to Catalent's latest financial reports the company's current revenue (TTM ) is โ‚น377.10 Billion. In 2023 the company made a revenue of โ‚น341.15 Billion a decrease over the revenue in the year 2022 that were of โ‚น393.64 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Catalent from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น368.89 B8.13%
2023 โ‚น341.15 B-13.33%
2022 โ‚น393.64 B17.97%
2021 โ‚น333.68 B31.67%
2020 โ‚น253.42 B30.21%
2019 โ‚น194.62 B11.88%
2018 โ‚น173.96 B18.48%
2017 โ‚น146.83 B13.96%
2016 โ‚น128.84 B5.68%
2015 โ‚น121.91 B4.16%
2014 โ‚น117.04 B4.83%
2013 โ‚น111.64 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น55.59 B-85.26%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น18.24 B-95.16%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น340.49 B-9.71%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚น27.09 B-92.82%๐Ÿ‡บ๐Ÿ‡ธ USA